[18F]FP-CIT and [18F]FDG PET findings in MSA patients with cognitive impairment
Objective: We investigated the brain dopaminergic system and glucose metabolism in multiple system atrophy (MSA) patients with cognitive impairment. Background: Since the first report of…Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)
Objective: To evaluate the accuracy of the IPD-MDS-PSP criteria to differentiate PSP-Richardson (PSP-R) from PSP-parkinsonism (PSP-P), the most common PSP phenotypes. Background: The new International…Patient Perspective in Multiple System Atrophy
Objective: To report patient and/ or caregiver perspective in Multiple System Atrophy (MSA). Background: The majority of literature on MSA’s natural history comes from single…Peripheral immune activation was associated with multiple system atrophy
Objective: Our aim is to clarify the correlations between peripheral immune activation and the prevalence as well as the disease severity of MSA. Background: Alpha-synuclein…Clinical indicators of advanced Parkinson’s disease: Evaluating diagnostic properties from retrospective analysis of multi-country, cross-sectional observational study
Objective: To measure the diagnostic properties of clinical indicators of advanced Parkinson Disease (APD). Background: Lack of consensus to define APD may lead to delay…Psychosocial Impact of dysarthria: Is speech intelligibility an effective measure outcome?
Objective: To identify if intelligibility or social repercussions of dysarthria determined quality of life in patients with different kinds of movement disorders. Background: Dysarthria in…Quality of Life and Psychiatric Comorbidities Comparisons in Patients with Functional (Psychogenic) and Organic Movement Disorders
Objective: To compare the quality of life (QoL) and psychiatric comorbidities of patients with functional (psychogenic) movement disorders (FMD) and patients with organic movements disorders…Predictors of health-related quality of life in Parkinson’s disease
Objective: To determine predictors of health-related quality of life (HRQoL) in patients with Parkinson’s disease (PD). Background: Determining the disease characteristics and symptoms associated with…The change of SIRT1 and HIF-1 in MPTP treated mouse
Objective: To study the changes of the expression of silent information adjustment factor 1 (SIRT1) and hypoxia inducing factor 1 (HIF-1) and changes in behavior…The BlueSky Project: monitoring motor and non-motor characteristics of people with Parkinson’s disease in the laboratory, a simulated apartment, and home and community settings
Objective: We present data collected for the BlueSky Project which aims to develop novel assessments of motor and non-motor function using mobile and wearable technology.…
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 177
- Next Page »